You are here  Home  

Hankey, Graeme J. (AU), MD, MBBS, FRGP, FRACP

Stroke Unit, Royal Perth Hospital, Perth, Australia


Graeme J. Hankey is Head of the Stroke Unit at Royal Perth Hospital, Western Australia, and Clinical Professor in the School of Medicine and Pharmacology of the University of Western Australia.

Dr Hankey received his undergraduate medical education at the University of Western Australia and trained in neurology at the Royal Perth Hospital; the Mayo Clinic, in Rochester, Minnesota, USA; and Western General Hospital, in Edinburgh, UK. Since 1992, he has held a full-time hospital appointment as a consultant neurologist and tries to integrate clinical practice with clinical research.

Dr Hankey’s main research interests include epidemiologic studies and clinical trials of treatment strategies for acute stroke and stroke prevention (such as the Perth Community Stroke Study, for which he is a co-principal investigator, and the VITAmins To Prevent Stroke (VITATOPS) trial, for which he is the principal investigator), atherothrombosis, antiplatelet therapy, and aspirin treatment failure. Dr Hankey was further a principal investigator in the Warfarin-Aspirin Recurrent Stroke Study (WARRS).

The International Stroke Society, Association of British Neurologists, and the Scientific Council of the American Stroke Association/American Heart Association are among the professional associations of which Dr Hankey is currently a member. The author or co-author of 6 books on stroke, Dr Hankey received the 1997 Royal Society of Medicine Medical Book Award, Advanced Author Book category, for Stroke: A Practical Guide to Management (Blackwell Scientific Publications, Oxford). He is also an associate editor of Stroke, a member of the editorial boards of the Cochrane Stroke Review Group, Practical Neurology, the Australian Journal of General Practice and Cerebrovascular Disease Foreign Medical Sciences, and a member of the advisory board of Cerebrovascular Diseases.

Dr Hankey has contributed more than 250 papers on cerebrovascular diseases to peer-reviewed medical journals such as Stroke, Lancet, Archives of Neurology, Cerebrovascular Diseases, Current Opinion in Neurology, JAMA, Annals of Neurology, Dysphagia, the New England Journal of Medicine, and Neurology, and has given more than 350 invited presentations at international, national, and local scientific meetings.

  • What are the results of the recently completed ROCKET and AVERROES trials and any other?